NeuroLogica acquires Xenon CT technology

The acquisition of the Xenon CT Perfusion technology is said to enhance NeuroLogica’s Portable CT capabilities in the emergency room, intensive care unit and operating room while increasing the company’s core competency of providing improved patient safety and care by bringing the highest quality imaging technology directly to the patient’s bedside.

According to the company, the combination of Portable CT and Xenon CT Perfusion, will now allow faster, more accurate and quantifiable information on cerebral blood flow in patients with a variety of neurological emergencies such as stroke and traumatic brain injury.

Colin McDonald, medical director for NeuroLogica, said: “The CereTom portable CT combined with the XeCT package is an extremely valuable diagnostic tool in monitoring patients with traumatic brain injury. This combination of technology will advance NeuroLogica’s vision of the right technology, for the right patient, at the right time.”